ARCHIVES

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Pediatric CCP Controversy Splits Group Leaders; National Consortium Forms; NCAB to Watch Closely

January 14, 1983

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014

HHS Secretary Tommy Thompson announced his resignation.

December 3, 2004

CTRC Wins Renewal Of Cancer Center Grant; New Mexico To Lead Systems Biology Center

September 4, 2009

FCRF Recompetition Notice Of Intent

September 19, 1980